ArticlePharmacology research & perspectives2024

Phase 1 pharmacokinetic and safety study of soticlestat in participants with mild or moderate hepatic impairment or normal hepatic function.

Wei Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.